Anticancer drug containing alpha,alpha,alpha-trifluorothymidine and thymidine phosphorylase inhibitor

Details for Australian Patent Application No. 2006209547 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Mita, Akira; Emura, Tomohiro

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006209547

PCT Pub. Number WO2006/080327

Priority 11/042,059 26.01.05 US; 2005-165156 06.06.05 JP

Filing date 25 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 26 May 2011

International Classifications

A61K 31/7068 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/080327 Priority application(s): WO2006/080327

26 May 2011 Application Accepted

  Published as AU-B-2006209547

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006209556-Process for production of 5-chloro-2,4-dihydroxypyridine

2006209543-Six-membered heterocyclic compound and the use thereof